Nicolas Palaskas, MD

Peer-Reviewed Articles

1. Ganatra, S, Barac, A, Armenian, SH, CAMBARERI, C, Denlinger, CS, Dent, S, Hayek, SS, Ky, B, Leja, M, Lucas, CH, Makwana, B, Palaskas, NL, VO, JB. Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies. Journal of the American College of Cardiology 87(5):654-682, 2026. e-Pub 2026. PMID: 41369617.
2. Ali A, Bourdillon M, Ali HR, Song J, Koutroumpakis E, Jewani P, Khalaf S, Hamzeh I, Kumar S, Palaskas NL, Durand JB, Iliescu C. CardioMEMS guided heart failure management in cardio-oncology patients: a tertiary care cancer center experience. Cardiooncology 11(1):67, 2025. e-Pub 2025. PMID: 40682155.
3. Ynalvez LA, Iliescu CA, Hamzeh IR, Deswal A, Palaskas NL. Treating a Metastatic Pericardial Tumor. JACC Case Rep 30(17):103867, 2025. e-Pub 2025. PMID: 40615195.
4. Kotla S, Lee J, Ko KA, Chen W, Samanthapudi VSK, Hoang O, Mejia GF, Li S, Schadler KL, Rivera LA, Imanishi M, Samperio KCT, Kim JH, Ostos-Mendoza KC, Mariscal-Reyes KN, Deswal A, Cooke JP, Fujiwara K, Palaskas NL, Koutroumpakis E, Gi YJ, Pathania R, Morrell C, Lorenzi PL, Tan L, Madhmud I, Hanssen NMJ, Yvan-Charvet L, Chini EN, Herrmann J, Vasquez HG, Shen YH, Martin JF, Xu H, Seeley EH, Burks JK, Brookes PS, Wang G, Le NT, Abe JI. Downregulation of LATS1/2 Drives Endothelial Senescence-Associated Stemness (SAS) and Atherothrombotic Lesion Formation. bioRxiv, 2025. e-Pub 2025. PMID: 40667385.
5. Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, Cautela J, Courand PY, Hayek SS, Zhu H, Zaha VG, Cheng RK, Alexandre J, Roubille F, Baldassarre LA, Chen YC, Baik AH, Laufer-Perl M, Tamura Y, Asnani A, Francis S, Gaughan EM, Rainer PP, Bailly G, Flint D, Arangalage D, Cariou E, Florido R, Narezkina A, Liu Y, Sandhu S, Leong D, Issa N, Piriou N, Heinzerling L, Peretto G, Crusz SM, Akhter N, Levenson JE, Turker I, Eslami A, Fenioux C, Moliner P, Obeid M, Chan WT, Ewer SM, Kassaian SE, Johnson DB, Nohria A, Ben Zadok OI, Moslehi JJ, Salem JE. Immune checkpoint inhibitor-associated myocarditis: a novel risk score. Eur Heart J, 2025. e-Pub 2025. PMID: 40569849.
6. Irizarry-Caro, JA, Song, J, Miller, C, Desai, S, Going, JJ, Fossas-Espinosa, J, Fatakdawala, M, Ali, A, Iliescu, C, Palaskas, NL, Deswal, A, Koutroumpakis, E. Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure. Cardiovascular Drugs and Therapy 39(3):553-562, 2025. e-Pub 2025. PMID: 38224416.
7. Fatakdawala, M, Ali, HR, Song, J, Irizarry-Caro, JA, Faiz, S, Kumar, S, Yusuf, SW, Durand, J, Iliescu, C, Palaskas, NL, Deswal, A, Koutroumpakis, E. Correlation of Natriuretic Peptides with Invasively Measured Intracardiac Filling Pressures in Patients With Cancer. JACC: CardioOncology 7(4):448-450, 2025. e-Pub 2025. PMID: 40366327.
8. Ruiz, JI, Zhao, B, Palaskas, NL, Deswal, A, Zhao, H, McQuade, JL, Suarez-Almazor, M. Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors. Journal of Immunotherapy and Precision Oncology 8(2):1-9, 2025. e-Pub 2025. PMID: 40224298.
9. Palaskas NL, King NE, Ostos-Mendoza KC, Ruiz-Jurado A, Ali HJ, Koutroumpakis E, Deswal A, Iliescu C, Durand JB, Karimzad K. Pacing Solutions for Immune Checkpoint Myocarditis and Associated Conduction Disorders. JACC Case Rep 30(8):103187, 2025. e-Pub 2025. PMID: 40250924.
10. Ali A, Koutroumpakis E, Song J, Booser D, Barcenas CH, Tripathy D, Barac A, Palaskas NL, Deswal A. Risk Stratification for Trastuzumab-Induced Cardiac Dysfunction and Potential Implications for Surveillance. JACC CardioOncol 7(3):203-215, 2025. e-Pub 2025. PMID: 40246379.
11. Chen YC, Dolladille C, Rao A, Palaskas NL, Deswal A, Lehmann L, Cautela J, Courand PY, Hayek S, Zhu H, Cheng RK, Alexandre J, Baldassarre LA, Roubille F, Laufer-Perl M, Asnani A, Ederhy S, Tamura Y, Francis S, Gaughan EM, Johnson DB, Flint DL, Rainer PP, Bailly G, Ewer SM, Aras MA, Arangalage D, Cariou E, Florido R, Peretto G, Itzhaki Ben Zadok O, Akhter N, Narezkina A, Levenson JE, Liu Y, Crusz SM, Issa N, Piriou N, Leong D, Sandhu S, Turker I, Moliner P, Obeid M, Heinzerling L, Chang WT, Stewart A, Venkatesh V, Du Z, Yadavalli A, Kim D, Chandra A, Zhang KW, Power JR, Moslehi J, Salem JE, Zaha VG. Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction. JACC CardioOncol 7(3):234-248, 2025. e-Pub 2025. PMID: 40246381.
12. BLOOM, MW, VO, JB, Rodgers, JE, FERRARI, AM, Nohria, A, Deswal, A, Cheng, RK, Kittleson, M, UPSHAW, JN, Palaskas, NL, BLAES, AN, Brown, SA, Ky, B, Lenihan, DJ, Maurer, MS, Fadol, AP, SKURKA, K, CAMBARERI, C, Barac, A. Cardio-Oncology and Heart Failure. Journal of Cardiac Failure 31(2):456-463, 2025. e-Pub 2025. PMID: 39414560.
13. Simbaqueba Clavijo C, Odaro O, Gandhi A, Koom-Dadzie K, Musaelyan A, Dickson K, Chua R, Bhise V, Amoateng M, Tomy S, Leal Alviarez D, Phyu EM, Bogdanich I, Andersen C, Sheshadri A, Palaskas NL, Halm J, Manzano J. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers (Basel) 17(3), 2025. e-Pub 2025. PMID: 39941771.
14. Jensen, G, Wang, X, Kuempel, J, Chen, Z, Yu, W, Palaskas, NL, Sobieski, M, Nguyen, N, Powell, RT, Stephan, C, Luo, W, Chang, J. Modeling immune checkpoint inhibitor associated myocarditis in vitro and its therapeutic implications. Journal of Molecular and Cellular Cardiology Plus 10, 2024. e-Pub 2024. PMID: 39742339.
15. Soto-Lanza F, Glick L, Chan C, Zhong L, Wilson N, Faiz S, Gandhi S, Naing A, Heymach JV, Shannon VR, Franco-Vega M, Liao Z, Lin SH, Palaskas NL, Wu J, Shroff GS, Altan M, Sheshadri A. Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis. Clin Lung Cancer 25(7):624-633.e2, 2024. e-Pub 2024. PMID: 39183094.
16. Walder JR, Faiz SA, Tummala S, Weathers SP, Palaskas NL, Buni M, Sheshadri A, Bashoura L. Diaphragmatic Myopathy Associated with Dual Immune Checkpoint Inhibitors in a Patient with Renal Cell Carcinoma. J Immunother Precis Oncol 7(4):304-307, 2024. e-Pub 2024. PMID: 39553443.
17. Ali, A, Lu, Y, Khalaf, SZ, Iliescu, C, Koutroumpakis, E, Yusuf, SW, Siddiqui, BA, Subudhi, SK, Deswal, A, Palaskas, NL. Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis. Journal of Nuclear Cardiology 39, 2024. e-Pub 2024. PMID: 39053574.
18. Siddiqui, BA, Palaskas, NL, Basu, S, Dai, Y, He, Z, Yadav, SS, Allison, JP, Sheth, RA, Tummala, S, Buja, LM, Bhattacharjee, M, Iliescu, C, Rawther-Karedath, A, Deswal, A, Wang, L, Sharma, P, Subudhi, SK. Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer Immunology Research 12(8):964-987, 2024. e-Pub 2024. PMID: 38768394.
19. Fayle, S, Palaskas, NL, Siddiqui, BA, McQuade, JL, Lin, JS, Subudhi, SK, Patel, A, Jenq, RR, Shah, AY, Spelman, AR, Sun, M, Marble, BH, Wang, Y. Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events. JNCCN Journal of the National Comprehensive Cancer Network 22(5), 2024. e-Pub 2024. PMID: 38190801.
20. Garg, M, Creechan, P, Sadeghpour, A, Abramov, D, Dani, SS, Ganatra, S, Al-Kindi, S, Michos, ED, Misra, A, Deswal, A, Palaskas, NL, Virani, SS, Nambi, V, Minhas, AK. Trends of Cardiovascular Disease–Related Mortality in Breast Cancer in the United States From 1999 to 2019. American Journal of Cardiology 221:110-112, 2024. e-Pub 2024. PMID: 38643926.
21. Ali, A, Caldwell, R, Pina, G, Beinart, N, Jensen, G, Yusuf, SW, Koutroumpakis, E, Hamzeh, IR, Khalaf, SZ, Iliescu, C, Deswal, A, Palaskas, NL. Elevated IL-6 and Tumor Necrosis Factor-α in Immune Checkpoint Inhibitor Myocarditis. Diseases 12(5), 2024. e-Pub 2024. PMID: 38785743.
22. Chen, X, Mumme, R, Corrigan, KL, Mukai-Sasaki, Y, Koutroumpakis, E, Palaskas, NL, Nguyen, C, Zhao, Y, Huang, K, Yu, C, Xu, T, Daniel, A, Balter, PA, Zhang, X, Niedzielski, JS, Shete, S, Deswal, A, Court, LE, Liao, Z, Yang, J. Deep learning–based automatic segmentation of cardiac substructures for lung cancers. Radiotherapy and Oncology 191, 2024. e-Pub 2024. PMID: 38122850.
23. Shatila, M, Eshaghi, F, Thomas, A, Kuang, AG, Shah, JS, Zhao, B, Naz, S, Sun, M, Fayle, S, Jin, J, Abudayyeh, A, Sheshadri, A, Palaskas, NL, Franco Vega, M, Gaeta, MS, Thomas, AS, Zhang, HC, Wang, Y. Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center. Cancers 16(2), 2024. e-Pub 2024. PMID: 38254858.
24. Fenioux, C, Abbar, B, Boussouar, S, Bretagne, M, Power, JR, Moslehi, JJ, Gougis, P, Amelin, D, Dechartres, A, Lehmann, LH, Courand, PY, Cautela, J, Alexandre, J, Procureur, A, Rozes, A, Leonard-Louis, S, Qin, J, Akhter, N, Aghel, N, Amidi, K, Anderson, E, Arangalage, D, Aras, M, Asnani, AH, Baldassarre, LA, Barovila, R, Barroso, AS, Bottinor, W, Bouali, A, Cariou, E, Chang, WT, Cheng, RK, Crusz, S, Deswal, A, Dietrich, PY, Dy, GK, Docq, C, Ewer, SM, Fernando, S, Flint, DL, Florido, R, Fukushima, S, Galli, E, Gaughan, EM, Habib, M, Haydon, A, Heinzerling, L, Itzhaki Ben Zadok, O, Issa, N, Palaskas, NL. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Nature medicine 29(12):3100-3110, 2023. e-Pub 2023. PMID: 37884625.
25. Noh, S, Bertini, CD, Mira-Avendano, I, Kaous, M, Patel, B, Faiz, S, Shannon, VR, Balachandran, D, Bashoura, L, Adachi, R, Evans, S, Dickey, BF, Wu, CC, Shroff, G, Manzano, JM, Granwehr, BP, Holloway, S, Dickson, KB, Mohammed, AD, Muthu, M, Song, H, Aroe, A, Aloia, TA, Lee Andrews, II, Badami, KK, Beird, H, Brock, K, Cata, JP, Dabaja, BS, Draetta, G, French, KE, Godoy, M, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Musunuru, TN, Nates, JL, Palaskas, NL, Ravi, V, Scheet, PA, Shete, S, Subbiah, IM, Tawbi, H, Woodman, SE, Chung, C, Khawaja, F, Sheshadri, A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer. Cancer medicine 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
26. Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, Stein F, Bretagne M, Ederhy S, Fenioux C, Hamwy O, Funck-Brentano E, Romano E, Pieroni L, Münster J, Allenbach Y, Anquetil C, Leonard-Louis S, Palaskas NL, Hayek SS, Katus HA, Giannitsis E, Frey N, Kaya Z, Moslehi J, Prifti E, Salem JE, Registry Contributors II. Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis. Circulation 148(6):473-486, 2023. e-Pub 2023. PMID: 37317858.
27. Ewer MS, Palaskas NL, Herson J. Cardiac Monitoring Guidelines in Clinical Trials and Post-Approval Surveillance for Patients Exposed to Anti-Cancer treatments: Do the Data Support the Recommendations?. J Pharmacol Exp Ther 386(2):164-168, 2023. e-Pub 2023. PMID: 37105580.
28. Abe JI, Imanishi M, Li S, Zhang A, Ko KA, Samanthapudi VSK, Lee LL, Bojorges AP, Gi YJ, Hobbs BP, Deswal A, Herrmann J, Lin SH, Chini EN, Shen YH, Schadler KL, Nguyen TH, Gupte AA, Reyes-Gibby C, Yeung SJ, Abe RJ, Olmsted-Davis EA, Krishnan S, Dantzer R, Palaskas NL, Cooke JP, Pownall HJ, Yoshimoto M, Fujiwara K, Hamilton DJ, Burks JK, Wang G, Le NT, Kotla S. An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and Atherosclerosis. Circ Res 133(1):25-44, 2023. e-Pub 2023. PMID: 37264926.
29. Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
30. Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
31. Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
32. Nguyen, MT, Imanishi, M, Li, S, Chau, KM, Banerjee, P, Velatooru, LR, Ko, KA, Samanthapudi, VS, Gi, YJ, Lee, LL, Abe, RJ, Fujiwara, E, Deswal, A, Lin, SH, Palaskas, NL, Dantzer, R, Fujiwara, K, Borchrdt, MK, Turcios, EB, Olmsted-Davis, EA, Kotla, S, Cooke, J, Wang, G, Abe, J, Le, NT. Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transition. Frontiers in Cardiovascular Medicine 10, 2023. e-Pub 2023. PMID: 37711550.
33. Ulndreaj A, Brinc D, Altan M, Pons-Belda OD, Fernandez-Uriarte A, Mu-Mosley H, Fattah F, von Itzstein MS, Soosaipillai A, Kulasingam V, Palaskas NL, Gerber DE, Diamandis EP, Heymach JV, Prassas I. Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study. Clin Chem Lab Med 61(1):154-161, 2023. e-Pub 2022. PMID: 36287134.
34. Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Itzhaki Ben Zadok O, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, Salem JE, registry contributors II. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. Eur J Cancer 177:197-205, 2022. e-Pub 2022. PMID: 36030143.
35. Kim JW, Monlezun D, Park JK, Chauhan S, Balanescu D, Koutroumpakis E, Palaskas N, Kim P, Hassan S, Botz G, Crommett J, Reddy D, Cilingiroglu M, Marmagkiolis K, Iliescu C. Post-cardiac arrest PCI is underutilized among cancer patients: Machine learning augmented nationally representative case-control study of 30 million hospitalizations. Resuscitation 179:43-49, 2022. e-Pub 2022. PMID: 35933056.
36. Potter AS, Patel A, Khawaja M, Chen C, Zheng H, Kaczmarek J, Gao F, Karimzad K, Song J, Koutroumpakis E, Khalaf S, Iliescu C, Deswal A, Palaskas NL. Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer. JACC CardioOncol 4(3):341-350, 2022. e-Pub 2022. PMID: 36213361.
37. Kim JW, Dayah TJ, Javaid A, Monlezun DJ, Balanescu DV, Donisan T, Karimzad K, Hakeem A, Boone DL, Palaskas N, Lopez-Mattei J, Kim PY, Durand JB, Song J, Balanescu SM, Yang EH, Herrmann J, Marmagkiolis K, Toutouzas K, Johnson NP, Iliescu CA. Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Medicina (Kaunas) 58(7), 2022. e-Pub 2022. PMID: 35888603.
38. Chauhan, S, Monlezun, DJ, Kim, JW, Goel, H, Hanna, A, Hoang, K, Palaskas, NL, Lopez-Mattei, J, Hassan, SA, Kim, P, Cilingiroglu, M, Marmagkiolis, K, Iliescu, C. Fractional Flow Reserve Cardio-Oncology Effects on Inpatient Mortality, Length of Stay, and Cost Based on Malignancy Type. Medicina (Lithuania) 58(7), 2022. e-Pub 2022. PMID: 35888578.
39. Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix CC, Feng L, Rondon G, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu SS, Shpall E, Wang M, Vega F, Westin J, Nastoupil LJ, Deswal A. Cardiovascular events in patients treated with chimeric antigen receptor t-cell therapy for aggressive B-cell lymphoma. Haematologica 107(7):1555-1566, 2022. e-Pub 2022. PMID: 34758610.
40. Power, JR, Alexandre, J, Choudhary, A, Ozbay, B, Hayek, SS, Asnani, AH, Tamura, Y, Aras, M, Cautela, J, Thuny, F, Gilstrap, L, Arangalage, D, Ewer, SM, Huang, S, Deswal, A, Palaskas, NL, Finke, D, Lehmann, LH, Ederhy, S, Moslehi, JJ, Salem, JE. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis. Archives of Cardiovascular Diseases 115(5):315-330, 2022. e-Pub 2022. PMID: 35595646.
41. Wang X, Palaskas NL, Hobbs BP, Abe JI, Nead KT, Yusuf SW, Hermann J, Deswal A, Lin SH. The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267613.
42. Shobayo F, Bajwa M, Koutroumpakis E, Hassan SA, Palaskas NL, Iliescu C, Abe JI, Mouhayar E, Karimzad K, Thompson KA, Deswal A, Yusuf S. Acute coronary syndrome in patients with cancer. Expert Rev Cardiovasc Ther 20(4):275-290, 2022. e-Pub 2022. PMID: 35412407.
43. Ahmed T, Mouhayar E, Song J, Koutroumpakis E, Palaskas NL, Yusuf SW, Lopez-Mattei J, Hassan SA, Kim P, Cilingiroglu M, Marmagkiolis K, Vaporciyan AA, Swisher S, Deswal A, Iliescu C. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med 9:916325, 2022. e-Pub 2022. PMID: 35711368.
44. Banerjee P, Olmsted-Davis EA, Deswal A, Nguyen MT, Koutroumpakis E, Palaskas NL, Lin SH, Kotla S, Reyes-Gibby C, Yeung SJ, Yusuf SW, Yoshimoto M, Kobayashi M, Yu B, Schadler K, Herrmann J, Cooke JP, Jain A, Chini E, Le NT, Abe JI. Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. J Cardiovasc Aging 2(3), 2022. e-Pub 2022. PMID: 35801078.
45. Imanishi M, Cheng H, Kotla S, Deswal A, Le NT, Chini E, Ko KA, Samanthapudi VSK, Lee LL, Herrmann J, Xu X, Reyes-Gibby C, Yeung SJ, Schadler KL, Yusuf SW, Liao Z, Nurieva R, Amir ED, Burks JK, Palaskas NL, Cooke JP, Lin SH, Kobayashi M, Yoshimoto M, Abe JI. Radiation therapy induces immunosenescence mediated by p90RSK. Front Cardiovasc Med 9:988713, 2022. e-Pub 2022. PMID: 36426217.
46. Safdar A, Ahmed T, Liu VY, Addoumieh A, Agha AM, Giza DE, Balanescu DV, Donisan T, Dayah T, Lopez-Mattei JC, Kim PY, Hassan S, Karimzad K, Palaskas N, Tsai JY, Iliescu GD, Yang EH, Herrmann J, Marmagkiolis K, Angelini P, Iliescu CA. Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med 9:1019284, 2022. e-Pub 2022. PMID: 36386379.
47. Koutroumpakis E, Niku A, Black CK, Ali A, Sadaf H, Song J, Palaskas N, Iliescu C, Durand JB, Yusuf SW, Lee HC, Buja LM, Deswal A, Banchs J. Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis. Front Cardiovasc Med 9:1073804, 2022. e-Pub 2022. PMID: 36762300.
48. Javaid, AI, Monlezun, DJ, Iliescu, G, Tran, P, Filipescu, A, Palaskas, NL, Lopez-Mattei, J, Hassan, SA, Kim, P, Madjid, M, Cilingiroglu, M, Charitakis, K, Marmagkiolis, K, Iliescu, C, Koutroumpakis, E. Stress cardiomyopathy in hospitalized patients with cancer. ESC Heart Failure 8(6):4626-4634, 2021. e-Pub 2021. PMID: 34612022.
49. Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek S, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehman L, Ederhy S, Moslehi J, Salem JE, Registry† II. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation 144(18):1521-1523, 2021. e-Pub 2021. PMID: 34723640.
50. Lehmann LH, Cautela J, Palaskas N, Baik AH, Meijers WC, Allenbach Y, Alexandre J, Rassaf T, Müller OJ, Aras M, Asnani AH, Deswal A, Laufer-Perl M, Thuny F, Kerneis M, Hayek SS, Ederhy S, Salem JE, Moslehi JJ. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review. JAMA Cardiol 6(11):1329-1337, 2021. e-Pub 2021. PMID: 34232253.
51. Palaskas NL, Segura A, Lelenwa L, Siddiqui BA, Subudhi SK, Lopez-Mattei J, Durand JB, Deswal A, Zhao B, Maximilian Buja L, Iliescu C. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail 23(10):1725-1735, 2021. e-Pub 2021. PMID: 34114291.
52. Javaid AI, Monlezu DJ, Iliescu G, Tran P, Eilipescu A, Palaskas N, Lopez-Mattei J, Hassan S, Madjid M, Cilingiroglu M, Charitakis K, Marmagkiolis K, c I, Koutroumpakis E. Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type. ESC Heart Failure, 2021. e-Pub 2021.
53. Balanescu DV, Aziz MK, Donisan T, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Song J, Ntim W, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cancer treatment resumption in patients with new-generation drug-eluting stents. Coron Artery Dis 32(4):295-301, 2021. e-Pub 2021. PMID: 33196581.
54. Monlezun DJ, Hostetter L, Balan P, Palaskas N, Lopez-Mattei J, Cilingiroglu M, Iakobishvili Z, Ewer M, Marmagkiolis K, Iliescu C. TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients. Cardiooncology 7(1):25, 2021. e-Pub 2021. PMID: 34183072.
55. Aldrich J, Pundole X, Tummala S, Palaskas N, Andersen CR, Shoukier M, Abdel-Wahab N, Deswal A, Suarez-Almazor ME. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Arthritis Rheumatol 73(5):866-874, 2021. e-Pub 2021. PMID: 33258544.
56. Kherallah RY, Harrison D, Preventza O, Silva GV, Dougherty KG, Coulter SA, Simpson L, Strickman NE, Mortazavi A, Palaskas N, Fish RD, Krajcer Z, Stainback RF, Gomez JCP, Livesay JJ, Coselli JS, Koneru S. Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis. Int J Cardiol 329:50-55, 2021. e-Pub 2021. PMID: 33359282.
57. Gill C, Lee M, Balanescu DV, Donisan T, Serauto Canache AJ, Palaskas N, Lopez-Mattei J, Kim PY, Song J, Yang EH, Cilingiroglu M, Kar B, Gregoric I, Marmagkiolis K, Iakobishvili Z, Iliescu C. Transcatheter and Surgical Aortic Valve Replacement Impact on Outcomes and Cancer Treatment Schedule. Int J Cardiol 326:62-70, 2021. e-Pub 2021. PMID: 32858137.
58. Abdulla A, Durand JB, Lopez-Mattei J, Palaskas N. A Rare Case of Testicular Teratoma Metastasizing to the Right Ventricle. JACC Case Rep 3(1):117-119, 2021. e-Pub 2021. PMID: 34317482.
59. Bravo-Jaimes K, Palaskas NL, Banchs J, Abelhad NI, Altaf A, Gouni S, Song J, Hassan SA, Iliescu C, Deswal A, Yusuf SW. Rate of Progression of Aortic Stenosis in Patients With Cancer. Front Cardiovasc Med 8:644264, 2021. e-Pub 2021. PMID: 33816575.
60. Monlezun DJ, Lawless S, Palaskas N, Peerbhai S, Charitakis K, Marmagkiolis K, Lopez-Mattei J, Mamas M, Iliescu C. Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer Patients. Front Cardiovasc Med 8:620857, 2021. e-Pub 2021. PMID: 33889598.
61. Heidari-Bateni G, Durand JB, Iliescu C, Gladish G, Deswal A, Patel AR, Kim P, Song J, Hassan S, Palaskas N, Baldassarre LA, Bucciarelli-Ducci C, Lopez-Mattei J. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Front Cardiovasc Med 8:734820, 2021. e-Pub 2021. PMID: 34765654.
62. Kim P, Masha L, Olson A, Iliescu C, Karimzad K, Hassan S, Palaskas N, Durand JB, Leung CH, Lopez-Mattei J. QT Prolongation in Cancer Patients. Front Cardiovasc Med 8:45, 2021. e-Pub 2021. PMID: 33718445.
63. Abe RJ, Savage H, Imanishi M, Banerjee P, Kotla S, Paez-Mayorga J, Taunton J, Fujiwara K, Won JH, Yusuf SW, Palaskas NL, Banchs J, Lin SH, Schadler KL, Abe JI, Le NT. Corrigendum: p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway. Front Cardiovasc Med 8:663486, 2021. e-Pub 2021. PMID: 33681312.
64. Koutroumpakis E, Hashmi SS, Powell C, Fatakdawala M, Pang J, Patel R, Thannoun T, Grable C, Damaraju S, Badruddin Mawji S, Lin K, Folivi M, Chauhan S, Shabbir MA, Hughes K, Peters TK, Lyubarova R, Damaraju S, Palaskas N, Deswal A, Garcia-Sayan E, Taegtmeyer H. Geographical Differences in Cardiovascular Comorbidities and Outcomes of COVID-19 Hospitalized Patients in the USA. Cardiology 146(4):481-488, 2021. e-Pub 2021. PMID: 33902039.
65. Wilson NR, Lee MT, Gill CD, Serauto Canache A, Donisan T, Balanescu DV, Song J, Palaskas N, Lopez-Mattei J, Cilingiroglu M, Marmagkiolis K, Iliescu CA. Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia. Front Cardiovasc Med 8:638943, 2021. e-Pub 2021. PMID: 33969007.
66. Agha AM, Palaskas N, Patel AR, DeCara J, Parwani P, Iliescu C, Durand JB, Kim P, Hassan S, Gladish G, Lee HC, Kaufman GP, Lopez-Mattei JC. Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis. Front Cardiovasc Med 8:626414, 2021. e-Pub 2021. PMID: 34268341.
67. Jacob R, Strati P, Palaskas N, Lopez-Mattei JC, Marmagkiolis K, Buja LM, Deswal A, Iliescu C. Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy. JACC Case Rep 2(13):2095-2100, 2020. e-Pub 2020. PMID: 34317115.
68. Palaskas NL, Deswal A. In heart failure, adding empagliflozin to medical therapy reduced a composite of CV death or HF hospitalization. Ann Intern Med 173(10):JC51, 2020. e-Pub 2020. PMID: 33197352.
69. Wang X, Palaskas NL, Yusuf SW, Abe JI, Lopez-Mattei J, Banchs J, Gladish GW, Lee P, Liao Z, Deswal A, Lin SH. Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer. J Thorac Oncol 15(10):1682-1690, 2020. e-Pub 2020. PMID: 32599073.
70. Balanescu DV, Donisan T, Deswal A, Palaskas N, Song J, Lopez-Mattei J, Kim PY, Durand JB, Doundoua D, Marmagkiolis K, Iliescu C. Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol 313:1-8, 2020. e-Pub 2020. PMID: 32320781.
71. Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Kim PY, Buja LM, McNamara DM, Kobashigawa JA, Durand JB, Iliescu CA. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy. Cardiovasc Pathol 47:107211, 2020. e-Pub 2020. PMID: 32268262.
72. Palaskas N, Lopez-Mattei J. Cancer therapy cardiotoxicity detection: understanding the limitations of cardiac imaging. Heart 106(11):791-792, 2020. e-Pub 2020. PMID: 32179588.
73. Mohamed MO, Lopez-Mattei JC, Parwani P, Iliescu CA, Bharadwaj A, Kim PY, Palaskas NL, Rashid M, Potts J, Kwok CS, Gulati M, Al Zubaidi AMB, Mamas MA. Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Nationwide insights from United States hospitalisations. Int J Clin Pract 74(5):e13476, 2020. e-Pub 2020. PMID: 31922635.
74. Quintana RA, Bui LP, Moudgil R, Palaskas N, Hassan S, Abe JI, Mouhayar E, Yusuf SW, Hernandez A, Banchs J. Speckle-Tracking Echocardiography in Cardio-Oncology and Beyond. Tex Heart Inst J 47(2):96-107, 2020. e-Pub 2020. PMID: 32603473.
75. Lopez-Mattei J, Verstovsek S, Fellman B, Iliescu C, Bhatti K, Hassan SA, Kim P, Gray BA, Palaskas NL, Grosu HB, Mamas MA, Faiz SA. Prevalence of pulmonary hypertension in myelofibrosis. Ann Hematol 99(4):781-789, 2020. e-Pub 2020. PMID: 32076825.
76. Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Iliescu C. Halloween in the Cath Lab: spider web pericardial effusion. Eur Heart J Cardiovasc Imaging 21(3):317, 2020. e-Pub 2020. PMID: 31501856.
77. Palaskas N, Lopez-Mattei J, Durand JB, Iliescu C, Deswal A. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc 9(2):e013757, 2020. e-Pub 2020. PMID: 31960755.
78. Abe RJ, Savage H, Imanishi M, Banerjee P, Kotla S, Paez-Mayorga J, Taunton J, Fujiwara K, Won JH, Yusuf SW, Palaskas NL, Banchs J, Lin SH, Schadler KL, Abe JI, Le NT. p90RSK-MAGI1 Module Controls Endothelial Permeability by Post-translational Modifications of MAGI1 and Hippo Pathway. Front Cardiovasc Med 7:542485, 2020. e-Pub 2020. PMID: 33304925.
79. Nguyen HL, Goebel M, Palaskas N, McCants D. Tropheryma whipplei- A rare and diagnostically challenging cause of culture-negative endocarditis. Int J Case Rep Images 11, 2020. e-Pub 2020.
80. Agha AM, Gill C, Balanescu DV, Donisan T, Palaskas N, Lopez-Mattei J, Hassan S, Kim PY, Charitakis K, Cilingiroglu M, Oo TH, Kroll M, Durand JB, Hirsch-Ginsberg C, Marmagkiolis K, Iliescu C. Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography. Front Cardiovasc Med 7:9, 2020. e-Pub 2020. PMID: 32118047.
81. Borovac JA, Kwok CS, Iliescu C, Lee HJ, Kim PY, Palaskas NL, Zaman A, Butler R, Lopez-Mattei JC, Mamas MA. Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis). Am J Cardiol 124(8):1190-1197, 2019. e-Pub 2019. PMID: 31395298.
82. Sudasena D, Balanescu DV, Donisan T, Hassan S, Palaskas N, Kim P, Karimzad K, Lopez-Mattei J, Arain S, Gould KL, Iliescu C. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol 19(4):382-387, 2019. e-Pub 2019. PMID: 30543051.
83. Kitkungvan D, Kalluru D, Lunagariya A, Sanchez L, Yusuf SW, Hassan S, Palaskas N, Mouhayar E, Banchs J. Safety of Transesophageal Echocardiography in Patients with Thrombocytopenia. J Am Soc Echocardiogr 32(8):1010-1015, 2019. e-Pub 2019. PMID: 31239084.
84. Balanescu DV, Donisan T, Dayah T, Palaskas N, Lopez-Mattei J, Kim P, Pinnix CC, Moudgil R, Balanescu SM, Herrmann J, Cilingiroglu M, Marmagkiolis K, Iliescu C. Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography. Int J Cardiovasc Imaging 35(5):759-760, 2019. e-Pub 2019. PMID: 30758691.
85. Palaskas N, Morgan J, Daigle T, Banchs J, Durand JB, Hong D, Naing A, Le H, Hassan SA, Karimzad K, Mouhayar E, Kim P, Lopez-Mattei J, Thompson K, Yusuf SW, Iliescu C. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol 123(8):1351-1357, 2019. e-Pub 2019. PMID: 30765065.
86. Donisan, T, Balanescu, DV, Iliescu, G, Lopez-Mattei, J, Palaskas, NL, Kim, P, Durand, J, Balanescu, SM, Marmagkiolis, K, Iliescu, C. Acute drops in ejection fraction in contemporary cardio-oncology. Revista Romana de Cardiologie 29(2):246-250, 2019. e-Pub 2019.
87. Balanescu DV, Monlezun DJ, Donisan T, Boone D, Cervoni-Curet F, Palaskas N, Lopez-Mattei J, Kim P, Iliescu C, Balanescu SM. A Cancer Paradox: Machine-Learning Backed Propensity-Score Analysis of Coronary Angiography Findings in Cardio-Oncology. J Invasive Cardiol 31(1):21-26, 2019. e-Pub 2019. PMID: 30611123.
88. Iliescu C, Balanescu DV, Donisan T, Giza DE, Muñoz Gonzalez ED, Cilingiroglu M, Song J, Mukerji SS, Lopez-Mattei JC, Kim PY, Palaskas N, Mouhayar EN, Durand JB, Marmagkiolis K. Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients with Acute Coronary Syndrome and Chronic Thrombocytopenia. Am J Cardiol 122(9):1465-1470, 2018. e-Pub 2018. PMID: 30180958.
89. Kitkungvan D, Yusuf SW, Moudgil R, Palaskas N, Guindani M, Juhee S, Hassan S, Sanchez L, Banchs J. Echocardiographic measures associated with the presence of left ventricular thrombus in patients with chemotherapy-related cardiac dysfunction. Echocardiography 35(10):1512-1518, 2018. e-Pub 2018. PMID: 30005128.
90. Potter A, Patel A, Khawaja M, Chen C, Zheng H, Kaczmarek J, Gao F, Karimzad K, Song J, Koutroumpakis E, Khalaf S, Iliescu C, Deswal A, Palaskas NL. Outcomes of stroke and bleeding by class of anticoagulant use for non-valvular atrial fibrillation in patients with active cancer. JACC:CardioOncology.

Invited Articles

1. Manohar H, Potter AS, Koutroumpakis E, Deswal A, Palaskas NL. Can We Mitigate Coronary Heart Disease Risk in Patients with Cancer?. Curr Atheroscler Rep 24(8):599-606, 2022. e-Pub 2022. PMID: 35624391.
2. Koutroumpakis E, Agrawal N, Palaskas NL, Abe JI, Iliescu C, Yusuf SW, Deswal A. Myocardial Dysfunction in Patients with Cancer. Heart Fail Clin 18(3):361-374, 2022. e-Pub 2022. PMID: 35718412.
3. Lipe DN, Chaftari P, Reyes-Gibby C, Palaskas NL. The evolving landscape of chimeric antigen receptor T-cell therapy associated cardiotoxicity. Am J Emerg Med 57:220-221, 2022. e-Pub 2022. PMID: 35246349.
4. Lipe DN, Palaskas NL, Chaftari P. Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis. J Med Toxicol 18(1):63-64, 2022. e-Pub 2022. PMID: 34227031.
5. Jacob R, Palaskas NL, Lopez-Mattei J, Hassan S, Kim P, Donisan T, Balanescu DV, Cilingiroglu M, Marmagkiolis K, Iliescu C. How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience. JACC CardioOncol 3(3):452-456, 2021. e-Pub 2021. PMID: 34604808.
6. Pushparaji B, Donisan T, Balanescu DV, Palaskas N, Kim P, Lopez-Mattei J, Cilingiroglu M, Hassan SA, Boudoulas KD, Marmagkiolis K, Hajjar LA, Iliescu CA. Interventional Strategies in Cancer-induced Cardiovascular Disease. Curr Oncol Rep 23(11):133, 2021. e-Pub 2021. PMID: 34570291.
7. Zarifa A, Kim JW, Lopez-Mattei J, Palaskas N, Iliescu C, Kim PY. Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management. Korean Circ J 51(7):579-597, 2021. e-Pub 2021. PMID: 34227272.
8. Zhang L, Reynolds KL, Lyon AR, Palaskas N, Neilan TG. The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer. JACC CardioOncol 3(1):35-47, 2021. e-Pub 2021. PMID: 33842895.
9. Palaskas NL, Koutroumpakis E, Deswal A. COVID-19 and Cardiovascular Health Among Patients with Cancer. Curr Cardiol Rep 22(12):171, 2020. e-Pub 2020. PMID: 33040241.
10. Simbaqueba CC, Aponte MP, Kim P, Deswal A, Palaskas NL, Iliescu C, Jahangir E, Yang EH, Steiner RE, Lopez-Mattei J. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. Journal of Immunotherapy and Precision Oncology 3(3):113-120, 2020. e-Pub 2020.
11. Palaskas NL, Lopez-Mattei J. The Role of Echocardiography in the Cancer Patient. Curr Cardiol Rep 22(10):1-11, 2020. e-Pub 2020. PMID: 32770406.
12. Raghunathan D, Palaskas NL, Yusuf SW, Eagle KA. Rise and fall of preoperative coronary revascularization. Expert Rev Cardiovasc Ther 18(5):249-259, 2020. e-Pub 2020. PMID: 32299259.
13. Pushparaji B, Marmagkiolis K, Miller C, Aziz M, Balanescu D, Donisan T, Palaskas N, Kim P, Lopez-Matei J, Cilingiroglu M, Hassan S, Iliescu C. State-of-the-art Review: Interventional Onco-Cardiology. Current Treatment Options in Cardiovascular Medicine 22(11), 2020. e-Pub 2020.
14. Parwani P, Co M, Ramesh T, Akhter N, Iliescu C, Palaskas N, Kim P, Gladish G. Differentiation of Cardiac Masses by Cardiac Magnetic Resonance Imaging. Current Cardiovascular Imaging Reports 13(1), 2020. e-Pub 2020.
15. Zarifa A, Lopez-Mattei J, Palaskas N, Iliescu C, Durand JB, Kim PY. Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity. Adv Exp Med Biol 1244:277-285, 2020. e-Pub 2020. PMID: 32301022.
16. Koutroumpakis E, Palaskas NL, Lin SH, Abe JI, Liao Z, Banchs J, Deswal A, Yusuf SW. Modern Radiotherapy and Risk of Cardiotoxicity. Chemotherapy 65(3-4):65-76, 2020. e-Pub 2020. PMID: 33049738.
17. Boone DL, Thanikachalam S, Cervoni-Curet F, Balanescu DV, Donisan T, Iliescu G, Palaskas N, lopez-Mattei J, Cilingiroglu M, Marmagkiolis K, Iliescu C. Coronary intervention in cancer patients: the need for personalized cardiac care. Romanian Journal of Cardiology 20(3):389-398, 2020. e-Pub 2020.
18. Palaskas N, Lopez-Mattei JC, Durand JB, Iliescu C, Deswal. Immune Checkpoint Inhibitor Myocarditis: Pathophysiology, Diagnosis, and Treatment. American Heart A 9(2):1-12, 2020. e-Pub 2020. PMID: 31960755.
19. Agha A, Zarifa A, Kim P, Iliescu C, Gladish G, Hassan S, Palaskas N, Durand JB, Lu Y, Lopez J. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. METHODIST DEBAKEY CARDIOVASC J 15(4):258-266, 2019. e-Pub 2019. PMID: 31988686.
20. Donisan T, Balanescu DV, Palaskas N, Lopez-Mattei J, Karimzad K, Kim P, Charitakis K, Cilingiroglu M, Marmagkiolis K, Iliescu C. Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin 37(4):469-486, 2019. e-Pub 2019. PMID: 31587788.
21. Hassan SA, Palaskas NL, Agha AM, Iliescu C, Lopez-Mattei J, Chen C, Zheng H, Yusuf SW. Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep 21(11):140, 2019. e-Pub 2019. PMID: 31745664.
22. Balanescu SM, Balanescu DV, Donisan T, Yang EH, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Cilingiroglu M, Marmagkiolis K, Kar B, Iliescu C. The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis?. Curr Cardiol Rep 21(8):83, 2019. e-Pub 2019. PMID: 31286273.
23. Zarifa A, Albittar A, Kim PY, Hassan S, Palaskas N, Iliescu C, Durand JB, Lopez-Mattei J. Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy. Curr Opin Cardiol 34(4):441-450, 2019. e-Pub 2019. PMID: 31082852.
24. Ghotra AS, Thompson K, Lopez-Mattei J, Bawa D, Hernandez R, Banchs J, Palaskas N, Iliescu C, Kim P, Yusuf SW, Hassan SA. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography 36(2):229-236, 2019. e-Pub 2019. PMID: 30569522.
25. Palaskas N, Patel A, Yusuf SW. Radiation and cardiovascular disease. Ann Transl Med 7(Suppl 8):S371, 2019. e-Pub 2019. PMID: 32016089.
26. Agha AM, Lopez-Mattei J, Donisan T, Balanescu D, Iliescu CA, Banchs J, Kim PY, Palaskas NL, Yusuf S, Gladish G, Hassan S. Multimodality imaging in carcinoid heart disease. Open Heart 6(1):e001060, 2019. e-Pub 2019. PMID: 31245014.
27. Donisan T, Balanescu D, Iliescu G, Lopez J, Palaskas N, Kim P, Durand JB, Balanescu S, Marmagkiolis K, Iliescu C. Acute drops in ejection fraction in contemporary cardio-oncology: old diagnosis, new offenders. Romanian Journal of Cardiology 29(2):246-250, 2019. e-Pub 2019.
28. Zarifa A, Salih M, Lopez-Mattei J, Lee HJ, Iliescu C, Hassan S, Palaskas N, Durand JB, Mouhayar E, Kim J, Kim P. Cardiotoxicity of FDA-approved immune checkpoint inhibitors: A rare but. Journal of Immunotherapy and Precision Oncology:68-77, 2018. e-Pub 2018.
29. Moudgil R, Hassan S, Palaskas N, Lopez-Mattei J, Banchs J, Yusuf SW. Evolution of echocardiography in subclinical detection of cancer therapy-related cardiac dysfunction. Echocardiography 35(6):860-868, 2018. e-Pub 2018. PMID: 29749652.
30. Palaskas N, Thompson K, Gladish G, Agha AM, Hassan S, Iliescu C, Kim P, Durand JB, Lopez-Mattei JC. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med 20(4):29, 2018. e-Pub 2018. PMID: 29556752.
31. Hassan SA, Palaskas N, Kim P, Iliescu C, Lopez-Mattei J, Mouhayar E, Mougdil R, Thompson K, Banchs J, Yusuf SW. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep 20(2):10, 2018. e-Pub 2018. PMID: 29423705.
32. Liu VY, Agha AM, Lopez-Mattei J, Palaskas N, Kim P, Thompson K, Mouhayar E, Marmagkiolis K, Hassan SA, Karimzad K, Iliescu CA. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Frontiers Cardiovasc Med 5(48):48, 2018. e-Pub 2018. PMID: 29868614.
33. Agha AM, Parwani P, Guha A, Durand JB, Iliescu CA, Hassan S, Palaskas NL, Gladish G, Kim PY, Lopez-Mattei J. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart 5(2):e000881, 2018. e-Pub 2018. PMID: 30305910.
34. Shah T, Palaskas N, Ahmed A. An Update on Gender Disparities in Coronary Heart Disease Care. Curr Atheroscler Rep 18(5):28, 2016. e-Pub 2016. PMID: 27029220.

Review Articles

1. López Moreno, SF, Lenz, SA, Casso-Chapa, B, Paniagua Bojorges, A, Kim, JH, Palaskas, NL, Nead, KT, Samanthapudi, VS, Mejia, G, Hoang, ON, Lee, J, Lin, SH, Herrmann, J, Wang, G, Yusuf, SW, Iliescu, C, Beinart, N, Manisty, C, Ushio-Fukai, M, Fukai, T, Ameri, P, Nurieva, R, Hildebrandt, MA, Schadler, KL, Koutroumpakis, E, Kotla, S, Le, NT, Abe, J. SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. Antioxidants 14(12), 2025. e-Pub 2025. PMID: 41462587.
2. Hachem AM, Desai A, Beinart N, Ostos-Mendoza KC, Rodriguez ASL, de Leon Derby RD, Ebrahimi S, Palaskas NL. Updates in Diagnosis and Treatment of Immune Checkpoint Inhibitor Myocarditis. Curr Cardiol Rep 27(1):78, 2025. e-Pub 2025. PMID: 40178703.
3. Rao, VU, Deswal, A, Lenihan, DJ, Dent, SF, López-Fernández, T, Lyon, AR, Barac, A, Palaskas, NL, Chen, MH, Villarraga, HR, Sadler, D, Campbell, CM, SKURKA, K, Wagner, MJ, Totzeck, M, Ruddy, KJ, Heidenreich, PA, Thomas, RJ, Addison, D, Ganatra, S, Cheng, RK, Reeves, D, Ghosh, AK, Herrmann, J. Quality-of-Care Measures for Cardio-Oncology. JACC: CardioOncology 7(3):191-202, 2025. e-Pub 2025. PMID: 40246378.
4. Jensen, G, Wang, X, Kuempel, J, Palaskas, NL, Chen, Z, Yu, W, Chen, Y, Mohammad, H, Luo, W, Chang, J. Immune checkpoint inhibitor-associated myocarditis. American Journal of Physiology - Heart and Circulatory Physiology 328(4):H734-H751, 2025. e-Pub 2025. PMID: 39925096.
5. Ostos-Mendoza, KC, Saraiba-Rabanales, V, Gutierrez-Gallegos, P, Wang, E, Koutroumpakis, E, Kumar, S, Khalaf, SZ, Ali, HR, Deswal, A, Palaskas, NL. Immune checkpoint inhibitor-associated myocarditis. Journal of Cardiovascular Aging 5(1), 2025. e-Pub 2025.
6. BLOOM, MW, VO, JB, Rodgers, JE, FERRARI, AM, Nohria, A, Deswal, A, Cheng, RK, Kittleson, M, UPSHAW, JN, Palaskas, NL, BLAES, AN, Brown, SA, Ky, B, Lenihan, DJ, Maurer, MS, Fadol, AP, SKURKA, K, CAMBARERI, C, Chauhan, C, Barac, A. Cardio-Oncology and Heart Failure. Journal of Cardiac Failure 31(2):415-455, 2025. e-Pub 2025. PMID: 39419165.
7. Ahmed O, King NE, Qureshi MA, Choudhry AA, Osama M, Zehner C, Ali A, Hamzeh IR, Palaskas NL, Thompson KA, Koutroumpakis E, Deswal A, Yusuf SW. Non-bacterial thrombotic endocarditis: a clinical and pathophysiological reappraisal. Eur Heart J 46(3):236-249, 2025. e-Pub 2025. PMID: 39565324.
8. Casso-Chapa B, Vazquez Gonzalez NA, Le NT, Palaskas NL, Nead KT, Eutsey LP, Samanthapudi VSK, Osborn AM, Lee J, Mejia G, Hoang O, Lin SH, Deswal A, Herrmann J, Wang G, Kirkland JL, Krishnan S, Wehrens XHT, Chini EN, Yusuf SW, Iliescu CA, Jain A, Burks JK, Seeley E, Lorenzi PL, Chau KM, Ostos Mendoza KC, Grumbach IM, Brookes PS, Hanssen NMJ, de Winther MPJ, Yvan-Charvet L, Kotla S, Schadler K, Abe JI. Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease. Arterioscler Thromb Vasc Biol 45(3):372-385, 2025. e-Pub 2025. PMID: 39817327.
9. Keam, S, Turner, N, Grande Kugeratski, F, Rico, R, Colunga-Minutti, JG, Poojary, R, Alekseev, S, Patel, A, Li, YJ, Sheshadri, A, Loghin, ME, Woodman, K, Aaroe, AE, Hamidi, S, Iyer, PC, Palaskas, NL, Wang, Y, Nurieva, R. Toxicity in the era of immune checkpoint inhibitor therapy. Frontiers in immunology 15, 2024. e-Pub 2024. PMID: 39247203.
10. Kandula VA, Smith GL, Rajaram R, Palaskas NL, Deswal A, Nasir K, Ali HR. A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health. Methodist Debakey Cardiovasc J 20(5):15-26, 2024. e-Pub 2024. PMID: 39525372.
11. Potter AS, Hulsurkar MM, Wu L, Narasimhan B, Karimzad K, Koutroumpakis E, Palaskas N, Deswal A, Kantharia BK, Wehrens XHT. Kinase Inhibitors and Atrial Fibrillation: Mechanisms of Action and Clinical Implications. JACC Clin Electrophysiol 9(4):591-602, 2023. e-Pub 2023. PMID: 37100538.
12. Jain, A, Casanova, D, Padilla, AV, Paniagua Bojorges, A, Kotla, S, Ko, KA, Samanthapudi, VS, Chau, KM, Nguyen, MT, Wen, J, Hernandez Gonzalez, SL, Rodgers, SP, Olmsted-Davis, EA, Hamilton, DJ, Reyes-Gibby, CC, Yeung, SJ, Cooke, J, Herrmann, J, Chini, EN, Xu, X, Yusuf, SW, Yoshimoto, M, Lorenzi, PL, Hobbs, BP, Krishnan, S, Koutroumpakis, E, Palaskas, NL, Wang, G, Deswal, A, Lin, SH, Abe, J, Le, NT. Premature senescence and cardiovascular disease following cancer treatments. Frontiers in Cardiovascular Medicine 10, 2023. e-Pub 2023. PMID: 37781317.
13. Koutroumpakis E, Deswal A, Yusuf SW, Abe JI, Nead KT, Potter AS, Liao Z, Lin SH, Palaskas NL. Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment. Curr Oncol Rep 24(5):543-553, 2022. e-Pub 2022. PMID: 35192118.
14. Lipe DN, Rajha E, Wechsler AH, Gaeta S, Palaskas NL, Alhajji Z, Viets-Upchurch J, Chaftari P. Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy. Am J Emerg Med 50:51-58, 2021. e-Pub 2021. PMID: 34274878.
15. Fadol AP, Patel A, Shelton V, Krause KJ, Bruera E, Palaskas NL. Palliative care referral criteria and outcomes in cancer and heart failure: a systematic review of literature. Cardiooncology 7(1):32, 2021. e-Pub 2021. PMID: 34556191.
16. Jimenez, DJ, Parikh, RV, Kamath, M, Calfon-Press, M, Moriarty, JM, Aksoy, O, Lopez-Mattei, J, Palaskas, NL, Iliescu, C, Yang, EH. Structural Transcatheter Cardiac Interventions in the Cardio-Oncology Population. Current Treatment Options in Cardiovascular Medicine 23(3), 2021. e-Pub 2021.
17. Pushparaji, B, Marmagkiolis, K, Miller, CK, Aziz, MK, Balanescu, DV, Donisan, T, Palaskas, NL, Kim, P, Lopez-Mattei, J, Cilingiroglu, M, Hassan, SA, Iliescu, C. State-of-the-art Review. Current Treatment Options in Cardiovascular Medicine 22(5), 2020. e-Pub 2020.
18. Boone, D, Thanikachalam, S, Cervoni-Curet, F, Balanescu, DV, Donisan, T, Iliescu, G, Palaskas, NL, Lopez-Mattei, J, Cilingiroglu, M, Marmagkiolis, K, Iliescu, C. Coronary intervention in cancer patients. Revista Romana de Cardiologie 30(3):389-398, 2020. e-Pub 2020.
19. Parwani, P, Co, M, Ramesh, T, Akhter, N, Iliescu, C, Palaskas, NL, Kim, P, Gladish, G, Stojanovska, J, Abramov, D, Lopez-Mattei, J. Differentiation of Cardiac Masses by Cardiac Magnetic Resonance Imaging. Current Cardiovascular Imaging Reports 13(1), 2020. e-Pub 2020.
20. Simbaqueba Clavijo, CA, Aponte, MP, Kim, P, Deswal, A, Palaskas, NL, Iliescu, C, Jahangir, E, Yang, EH, Steiner, RE, Lopez-Mattei, J. Cardiovascular complications of chimeric antigen receptor t-cell therapy. Journal of Immunotherapy and Precision Oncology 3(3):113-120, 2020. e-Pub 2020. PMID: 35663258.
21. Fadol AP, Palaskas NL, Ewer MS, Deswal A. An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020. Cardiooncology 6(1):20, 2020. e-Pub 2020. PMID: 32944289.
22. Zarifa, A, Salih, M, Lopez-Mattei, J, Lee, HJ, Iliescu, C, Hassan, SA, Palaskas, NL, Durand, J, Mouhayar, E, Kim, J, Kim, P. Cardiotoxicity of fda-approved immune checkpoint inhibitors. Journal of Immunotherapy and Precision Oncology 1(2):68-77, 2018. e-Pub 2018.

Other Articles

1. Fenioux, C, Abbar, B, Boussouar, S, Bretagne, M, Power, JR, Moslehi, JJ, Gougis, P, Amelin, D, Dechartres, A, Lehmann, LH, Courand, PY, Cautela, J, Alexandre, J, Procureur, A, Rozes, A, Leonard-Louis, S, Qin, J, Akhter, N, Aghel, N, Amidi, K, Anderson, E, Arangalage, D, Aras, M, Asnani, AH, Baldassarre, LA, Barovila, R, Barroso, AS, Bottinor, W, Bouali, A, Cariou, E, Chang, WT, Cheng, RK, Crusz, S, Deswal, A, Dietrich, PY, Dy, GK, Docq, C, Ewer, SM, Fernando, S, Flint, DL, Florido, R, Fukushima, S, Galli, E, Gaughan, EM, Habib, M, Haydon, A, Heinzerling, L, Itzhaki Ben Zadok, O, Issa, N, Palaskas, NL Correction to. Nature medicine 30(3):910, 2024. PMID: 38172633.
2. Fenioux, C, Abbar, B, Boussouar, S, Bretagne, M, Power, JR, Moslehi, J, Gougis, P, Amelin, D, Dechartres, A, Lehmann, LH, Courand, PY, Cautela, J, Alexandre, J, Procureur, A, Rozes, A, Leonard-Louis, S, Qin, J, Akhter, N, Aghel, N, Amidi, K, Anderson, E, Arangalage, D, Aras, M, Asnani, AH, Baldassarre, LA, Barovila, R, Barroso, AS, Bottinor, W, Bouali, A, Cariou, E, Chang, WT, Cheng, RK, Crusz, S, Deswal, A, Dietrich, PY, Dy, GK, Docq, C, Ewer, SM, Fernando, S, Flint, DL, Florido, R, Fukushima, S, Galli, E, Gaughan, EM, Habib, M, Haydon, A, Heinzerling, L, Itzhaki Ben Zadok, O, Issa, N, Palaskas, NL Author Correction. Nature medicine 29(12):3268, 2023. PMID: 38012317.
3. Palaskas N Expert Comment on Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis. Practice Update, online, 2020.
4. Palaskas N Expert Comment on Hypertension and Incident Cardiovascular Events Following Ibrutinib Initiation. Practice Update, online, 2019.
5. Palaskas N Experts Comment for Anticoagulation of Cancer Patients With Non‐Valvular Atrial Fibrillation Receiving Chemotherapy: Guidance From the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Practice Update, online, 2019.
6. Balanescu DV, Donisan T, Palaskas NL, Iliescu C Emerging Concerns in Cardio-Oncology: Immune Checkpoint Inhibitor Cardiotoxicity, 2019.
7. Palaskas NL.

Editorials

1. Ostos-Mendoza, KC, L. McQuade, J, Palaskas, NL. Troponin Surveillance in Patients Receiving Immune Checkpoint Inhibitors. JACC: CardioOncology 7(6):722-724, 2025. PMID: 41130642.
2. Palaskas NL, Siddiqui BA, Deswal A. Steroids in Immune Checkpoint Inhibitor Myocarditis. JACC CardioOncol 6(5):800-803, 2024. PMID: 39479336.
3. Lopez-Mattei, J, Palaskas, NL, Iliescu, C. Skip Soft Definitions and Focus on Hard Endpoints. JACC: CardioOncology 1(2):218-220, 2019. PMID: 34396185.
4. Lopez-Mattei JC, Palaskas N, Iliescu C. Skip Soft Definitions and Focus on Hard Endpoints. JACC:CardioOncology 1(2):218-220, 2019.

Abstracts

1. Ahmed T, Safdar A, Song J, Banchs J, Kim P, Palaskas NL, Iliescu C. Predictors of Recurrent Pericardial Effusion in Cancer Patients Requiring Pericardiocentesis. Circulation 144(Suppl_1):A12836-A12836, 2021. e-Pub 2021.
2. Agrawal N, Monlezun D, Grable C, Graham J, Marmagkiolis K, Chauhan S, Hostetter L, Cilingiroglu M, Dhoble A, Charitakis K, Smalling RW, Palaskas NL, Arain SA, Iliescu C. Chronic Total Occlusion Racial and Income Inequities by Mortality and Cost: Propensity Score and Machine Learning Augmented Nationally Representative Case-Control Study of 30 Million Hospitalizations. Circulation 144(Suppl_1):A13212-A13212, 2021. e-Pub 2021.
3. Monlezun D, Agrawal N, Palaskas NL, Cilingiroglu M, Marmagkiolis K, Dhoble A, Arain SA, Iliescu C. Racial and Income Inequities in Cardiovascular Disease in Cancer versus Non-Cancer Patients: Propensity Score and Machine Learning Augmented Nationally Representative Case-Control Study of Mortality and Cost Among 30 Million Hospitalizations. Circulation 144(Suppl_1):A14107-A14107, 2021. e-Pub 2021.
4. Patel A, Khawaja M, Chen CR, Zheng H, Morgan J, Kaczmarek J, Gao F, Karimzad K, Song J, Lopez-Mattei J, Iliescu C, Deswal AM, Palaskas NL. Outcomes of Stroke and Bleeding by Class of Anticoagulant Use for Non-Valvular Atrial Fibrillation in Patients With Active Cancer. Circulation 144(Suppl_1):A11839-A11839, 2021. e-Pub 2021.
5. Donisan T, Balanescu D, Aziz M, Song J, Ntim W, Palaskas N, Lopez-Mattei JC, Kim PY, Cilingiroglu M, Marmagkiolis K, Deswal A, and Iliescu C. Early Resumption of Cancer Treatment After Percutaneous Coronary Intervention: Impact on cardiovascular outcomes. J Am Coll Cardio 75(11_Supplement_1):1407, 2020. e-Pub 2020.
6. Agha A, Chen N, Chen C, Zheng H, Morgan J, Khan A, Lopez-Mattei JC, Lee M, Iliescu C, Palaskas N. Checkpoint Inhibitors and Their Association with Valvular Dysfunction Among Cancer Patients. J Am Coll Cardiol 75(11_Supplement_1):1663, 2020. e-Pub 2020.
7. Serauto A, Lee M, Lopez-Mattei J, Gill C, Donisan T, Balanescu D, Marmagkiolis K, Palaskas N, Kim P, Deswal A, Iliescu C. Hematological Malignancies with Thrombocytopenia Undergoing Primary Percutaneous Pericardiocentesis: Periprocedural (30-day) Overall Survival Analysis. Journal of the American College of Cardiology 75(11 supplement 1):1510-1510, 2020. e-Pub 2020.
8. Monlezun D, Gaiba R, Marmagkiolis K, Cilingiroglu M, Lopez-Mattei J, Kim P, Chauhan S, Hoang K, Folvi M, Hostetter L, Lee S, Yalamanchi A, Tamil M, Chen J, Thannoun T, Grable C, Chen N, Thomason N, Okirie V, Palaskas N, Colen J, DeSnyder S, Iliescu C. Propensity Score and Machine Learning Augmented Nationally Representative Case-Control Study of 30 million+ Hospitalization. Journal of the American College of Cardiology 75(11 supplement 1):3625-3625, 2020. e-Pub 2020.
9. Aziz M, Balanescu D, Donisan T, Song J, Palaskas N, Lopez-Mattei J, Kim P, Cilingiroglu M, Hermann J, Marmagkiolis K, Deswal A, Iliescu C. Intracoronary imaging-guided Discontinuation of Dual Antiplatelet Therapy in Stented Patients Requiring Expedited Cancer Treatment. Journal of the American College of Cardiology 75(11 supplement 1):1408-1408, 2020. e-Pub 2020.
10. Monlezun D, Folivi M, Palaskas N, Lopez-Mattei J, Kim P, Chauhan S, Hoang K, Gaiba R, Hostetter L, Yalamanchi A, Tamil M, Chen J, Thannoun T, Grable C, Chen N, Thomason N, Boone D, Okirie V, Lee S, You N, Rodriguez-Bigas M, Iliescu C. PCI Provides Costly Mortality Reductions for Colon Cancer Patients: Propensity Score and Machine Learning Supported Nationally Representative Case-Control Study of 30+ Million Hospitalizations. Cardiovascular Interventions 13(4 Supplement S):S28-S28, 2020. e-Pub 2020.
11. Kotla S, Ko KA, Imanishi M, Banchs J, Palaskas NL, Yusuf SW, Fujiwara K, Le NT, Deswal A, Chung C, Lin SH, Abe J. P90rsk-mediated Erk5 S496 Phosphorylation and Poly (adp-ribose) Polymerase (parp) Activation Promote Monocyte/macrophage Priming in Mouse and Cancer Patients After Radiation Therapy (rt). Arteriosclerosis, Thrombosis, and Vascular Biology 40:A330, 2020. e-Pub 2020.
12. Graham J, Aziz M, Donisan T, Balanescu DV, Palaskas N, Lopez-Mattei J, Cilingiroglu M, Balanescu SM, Ganim NM, Lin HY, Marmagkiolis K, Molony DA, Durand JB, Iliescu C. The impact of therapeutic mediastinal radiation on stent healing in cancer patients: An optical coherence tomography study. Journal of Clinical Oncology 38(15_suppl):e19096, 2020. e-Pub 2020.
13. Aldrich J, Pundole X, Tummala S, Andersen C, Shoukier M, Abdel-Wahab N, Palaskas N, Deswal A, Suarez-Almazor ME. Incidence and outcomes of immune checkpoint inhibitor-related myositis. Journal of Clinical Oncology 38(15_suppl):e15128, 2020. e-Pub 2020.
14. Salamo O, Lopez-Mattei J, Sargsyan L, Kaous M, Iliescu C, Palaskas N, Bashoura L, Patel B, Faiz S. Pulmonary Hypertension in Patients with Cancer. Chest 158(4):A2230, 2020. e-Pub 2020.
15. Fatakdawala M, Pang J, Patel R, Thannoun T, Grable C, Damaraju S, Mawji SB, Folivi M, Chauhan S, Powell C, Shabbir MA, Lyubarova R, Damaraju S, Palaskas NL, Deswal AM, Taegtmeyer H, Garcia-Sayan E, Koutroumpakis E. Electrocardiographic Findings and Their Associations With Adverse Outcomes in Hospitalized Patients With COVID-19. Circulation 142(Suppl_3):A16107, 2020. e-Pub 2020.
16. Nowatzke J, Power JR, Meijers WC, Orimoloye O, Fenioux C, Tamura Y, Cautela J, Lehmann LH, Finke D, Hayek S, Azam TU, Asnani A, Mehegan T, Weppler A, Baik AH, Aras MA, Narezkina A, Arangalage D, Rocher F, Alexandre G, Palaskas NL, Salem J, Moslehi J. Natural History of Immune Checkpoint Inhibitor Associated Myocarditis With Preserved Ejection Fraction. Circulation 142(Suppl_3):A15365, 2020. e-Pub 2020.
17. Koutroumpakis E, Thannoun T, Pang J, Patel R, Grable C, Damaraju S, Mawji SB, Folivi M, Chauhan S, Fatakdawala M, Powell C, Shabbir MA, Philbin E, Lyubarova R, Damaraju S, Palaskas NL, Deswal A, Taegtmeyer H, Garcia-Sayan E. Baseline Comorbidities and Cardiac Biomarkers are Associated With In-hospital Mortality of Covid-19 Patients. Circulation 142(Suppl_3):A16352, 2020. e-Pub 2020.
18. Power JR, Alexandre J, Choudhary A, Ozbay B, Palaskas NL, Lehmann LH, De F, Cautela J, Thuny F, Tamura Y, Hayek SS, Azam TU, Asnani A, Mehegan T, MAs A, Baik AH, Gilstrap L, Laufer-Perl M, Arangalage D, Ewer S, Martini M, Nowatzke J, Orimoloye OA, Brinkley DM, Meijers WC, Fenioux C, Ederhy S, Moslehi JJ, Salem J. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Associated Myocarditis. Circulation 142(Suppl_3):A14843, 2020. e-Pub 2020.
19. Lawless S, Monlezun D, Palaskas N, Lopez-Mattei J, Kim P, Marmagkiolis K, Iliescu C. Percutaneous Coronary Intervention Provides a Unique Benefit to Inpatient Mortality for Cancer Patients With Coronary Artery Disease. Circulation 140(Suppl 1):A14504-A14504, 2019. e-Pub 2019.
20. Balanescu DV, Donisan T, Lee M, Tran P, De Sirkar S, Palaskas N, Lopez-Mattei J, Kim PY, Iliescu G, Balanescu SM, Marmagkiolis K, Iliescu C. Invasive versus medical management of non-ST elevation myocardial infarction in cancer patients: knowledge is bliss. European Heart Journal 40(2233-2233), 2019. e-Pub 2019.
21. Mohamed MO, Lopez-Mattei JC, Iliescu CA, Purwani P, Bharadwaj A, Kim PY, Palaskas NL, Rashid M, Potts JE, Kwok CS, Gulati M, Zubaidi AB, Mamas M. Acute myocardial infarction in patients with Leukaemia: A national analysis of prevalence, predictors and outcomes in United States hospitalisations (2004 to 2014). European Heart Journal 40(Suppl 1):289-289, 2019. e-Pub 2019.
22. Tran P, Monlezum D, De Sirkar S, Iliescu G, Kim P, Lopez-Mattei J, Palaskas N, Durand JB, Iliescu C. Takotsubo cardiomyopathy mortality and costs in cancer, PCI, and racial disparities: propensity score adjusted machine learning guided analysis of 6+ million inpatient admissions. Journal of Cardiac Failure 25(8)(S60), 2019. e-Pub 2019.
23. Iliescu C, Balanescu D, Hassan S, Lopez-Mattei J, Palaskas N, Dasari A, Halperin D, Yao J, Kar B, Gregoric I, Nathan I, Durand JB, Karimzad K, Kim P, Iliescu G, Balanescu S, Marmagkiolis K, Donisan T. Predictors of Mortality Following Cardiac Surgery for Carcinoid Heart Disease. Journal of Clinical Oncology 37(15 suppl):e15692-e15692, 2019. e-Pub 2019.
24. Khan A, Zhang H, Chen C, Morgan J, Zarifa A, Shahid M, Song J, Naing A, Lopez-Mattei J, Durand JB, Kim P, Iliescu C, Palaskas. Impact of Pericardial Effusions for Patients Receiving Immune Checkpoint Inhibitors. Journal of Clinical Oncology 37(15 suppl):e14121-e14121, 2019. e-Pub 2019.
25. Khan A, Amidi O, Hess K, Ewer MS, Yusuf SW, Banchs J, Palaskas N. Defining Cardiotoxicity of Doxorubicin and Trastuzumab. Journal of Clinical Oncology 37(15 suppl):e23097-e23097, 2019. e-Pub 2019.
26. Abdulla A, Durand JB, Lopez-Mattei J, Palaskas N. A Rare Case of Germ Cell Tumor Metastasizing to the Heart. Journal of the American College of Cardiology 2019 73(9 supplement 1):2620, 2019. e-Pub 2019.
27. Balanescu D, Donisan T, Monlezun D, Boone D, Cervoni Curet F, Balanescu S, Lee M, Palaskas N, Lopez-Mattei JC, Kim PY, Charitakis K, Marmagkiolis K, Iliescu C. A case-control analysis of coraonry angiography findings and cardiovascular risk factors of cancer and non-cancer patients. SCAI 2019 Scientific Sessions, 2019. e-Pub 2019.
28. Tran P, Monlezum D, De Sirkar S, Iliescu G, Kim P, Lopez-Mattei J, Palaskas N, Durand JB, Iliescu C. Takotsubo cardiomyopathy preferentially impacts patients by primary malignancy type: multi-center nationally representative analysis of over 6 million hospitalizations. Journal of Cardiac Failure 25(8)(S94), 2019. e-Pub 2019.
29. Lee M, Gill C, Seauto Canache A, Donisan T, Balanescu D, Marah N, Stone D, Stone J, Boone D, Cervoni Curet F, Agha A, Iliescu C, Palaskas N. Pericardiocentesis in thrombocytopenic cancer patients. European Heart Journal 40(Suppl_1)(ehz747.0284), 2019. e-Pub 2019.
30. Borovac JA, Kwok CS, Konopleva M, Kim PY, Palaskas N, Zaman A, Butler R, Lopez-Mattei JC, Mamas MA. Percutaneous coronary intervention and clinical outcomes in patients with lymphoma: a 10-year period United States nationwide inpatient sample (NIS) analysis. European Heart Journal 40(Suppl_1)(ehz747.0282), 2019. e-Pub 2019.
31. Bateni GH, Durand JB, Iliescu C, Mouhayar E, Palaskas N, Gladish G, Chohan J, Sudasena D, Hassan S, Kim P, Parwani P, Jazayeri M, Lopez-Mattei J. Cardiac Magnetic Resonance Clinical Impact in Management of Cardiomyopathy in a Cancer Center. Circulation 140(Suppl_1)(A15308-A15308), 2019. e-Pub 2019.
32. Agha A, Chen N, Chen C, Zheng H, Morgan J, Khan A, Lopez-Mattei J, Moudgil R, Iliescu C, Palaskas N. Predictors of Mortality Among cancer Patients Treated with Checkpoint Inhibitors. Circulation 140(Suppl_1)(A15055-A15055), 2019. e-Pub 2019.
33. Hostetter L, Monlezum D, Thannoun T, Pabba K, Lawless S, Patel R, Grable C, Zheng D, Chen N, Palaskas N, Lopez-Mattei J, Kim P, Cilingiroglu M, Marmagkiolis K, Iliescu C. Transcatheter Aortic Valve Replacement Reduces Inpatient Costs and Stay for Cancer Patients with Severe Aortic Stenosis. Circulation 140 (Suppl_1)(A14614-A14614), 2019. e-Pub 2019.
34. Gill C, Lee M, Canache A, Donisan T, Balanescu D, Raghunathan D, Song J, Palaskas N, Lopez-Mattei JC, Kim PY, Kar B, Gregoric I, Cilingiroglu M, Smalling R, Marmagkiolis K, Iliescu C. Transcatheter aortic valve replacement is a viable option to improve mortality in cancer patients with severe aortic stenosis considered high risk for surgical aortic valve replacement. SCAI 2019 Scientific Sessions, 2019. e-Pub 2019.
35. Zheng H, Morgan J, Chen C, Kaczmarek J, Ab K, Kim PY, Durand JB, Lopez-Mattei JC, Iliescu C, Palaskas N. Tissue is the issue! Immune checkpoint inhibitor myocarditis. SCAI 2019 Scientific Sessions, 2019. e-Pub 2019.
36. Agha A, Gill C, Donisan T, Balanescu D, Lee M, Raghunathan D, Song J, Palaskas N, Lopez-Mattei JC, Kim PY, Durand JB, Cilingiroglu M, Marmagkiolis K, Iliescu C. The utility of thromboelastography (TEG) among cancer patients undergoing coronary angiography. SCAI 2019 Scientific Sessions, 2019. e-Pub 2019.
37. Lee M, Dayah T, Balanescu D, Donisan T, Karimzad K, Hakeem A, Boone D, Palaskas N, Lopez-Mattei J, Kim P, Durand JB, Song J, Balanescu SM, Yang EH, Herrmann J, Marmagkioli K, Toutouzas K, Johnson N, Iliescu C. Reclassification of Treatment Strategy With Fractional Flow Reserve in Cancer Patients With Coronary Artery Disease. JACC: Cardiovascular Interventions 12(4 supplement):s17-S18, 2019. e-Pub 2019.
38. Agha A, Gill C, Balanescu D, Donisan T, Boone D, Song J, Iliescu G, Palaskas N, Lopez-Mattei J, Kim P, Doundoua D, Marmagkiolis K, Durand JB, Iliescu C. Coronary Angiography Among Cancer Patients: Determining a Safe Platelet Threshold. Journal of the American College of Cardiology 73(9 supplement 1):1289, 2019. e-Pub 2019.
39. McDermott L, Laeeq R, Palaskas N, Moudgil R, Kim P, Yusuf S, Hassan S, Banchs J, Donisan T, Balanescu DV, Iliescu C, Durand JB, lopez-Mattei J. Using Dobutamine Stress Echocardiography to Predict the Recovery of Left Ventricular Function in Cancer Patients Receiving Chemotherapy. Journal of the American College of Cardiology 73(9 supplement 1):1604, 2019. e-Pub 2019.
40. Tran P, Monlezum D, De Sirkar S, Iliescu G, Kim P, Lopez-Mattei J, Palaskas N, Durand JB, Iliescu C. Takotsubo cardiomyopathy in HFrEF and thrombocytopenia: Multi-center machine learning supported analysis of mortality and costs among 6+ million hospitalizations. Journal of Cardiac Failure 25(8)(S61), 2019. e-Pub 2019.
41. Amidi O, Donisan T, Balanescu D, Hassan S, Iliescu C, Lopez-Mattei J, Banchs J, Palaskas N. Baseline Echocardiographic Parameters to Predict Cardiotoxicity in Breast Cancer Patients Receiving Chemotherapy. Journal of the American College of Cardiology 73(9 supplement 1):788, 2019. e-Pub 2019.
42. Iliescu C, Balanescu D, Song J, Palaskas N, Karimzad K, Kim P, Lopez-Mattei J, Durand JB, Jipescu D, Gonzalez E, Ntim W, Balanescu S, Marmagkiolis K, Cilingiroglu M, Donisan T. Early Dual Antiplatelet Therapy Discontinuation in Cancer Patients with Newer Generation Drug-Eluting Stents: A Single Center Experience. Journal of the American College of Cardiology 73(9 supplement 1):1291, 2019. e-Pub 2019.
43. Upadhyay A, Lopez-Mattei J, Kim P, Iliescu C, Durand JB, Palaskas N, Hassan S, Thompson K, Mouhayar E. Diagnostic Performance of High Sensitivity Troponin in Cancer Patients. Journal of the American College of Cardiology 73(9 supplement 1):209, 2019. e-Pub 2019.
44. Donisan T, Balanescu D, Sudasena D, Dayah T, Giza D, Rodriguez De Armas L, Agarwal M, Iliescu G, Palaskas N, Lopez-Mattei J, Kim P, Durand JB, Cortes J, Iliescu. Echocardiographic Assessment of Cardiotoxicity in Chronic Myelogenous Leukemia Patients Receiving Dasatinib or Nilotinib. Circulation Suppl_1:A11235, 2018. e-Pub 2018.
45. Boone D, Monlezun D, Cervoni-Curet F, Chohan J, Sunny J, Bhatti K, Balanescu D, Donisan T, Iliescu G, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Durand JB, Balanescu S, Marmagkiolis K, Gonzalez E, Okwuosa, Iliescu C. Malignancy Type Impacts Coronary Lesion Severity and Location: Multivariable Regression with Concurrent Machine Learning-Backed Case-Control Analysis. Circulation 138(A16512), 2018. e-Pub 2018.
46. Boone D, Monlezun D, Cervoni-Curet F, Chohan J, j S, k B, Iliescu G, Donisan T, Balanescu D, Palaskas N, Lopez-Mattei J, Hassan S, Kim P, Marmagkiolis K, Iliescu C. TCT-150 Cardiovascular disease and percutaneous coronary intervention in hematological malignancies: knowledge is power. the American College of Cardiology 72(13 supplement):64, 2018. e-Pub 2018.
47. Balanescu DV, Liu VY, Donisan T, Agha AM, Lopez-Mattei JC, Giza DE, Iliescu GD, Palaskas N, Kim PY, Boone DL, Yang EH, Herrmann J, Marmagkiolis K, Angelini P, Iliescu CA. Clinical features and outcomes of patients with chemotherapy-induced Takotsubo stress cardiomyopathy. European Heart Journal 39(Suppl 1):1253, 2018. e-Pub 2018.
48. Lopez-Mattei J, Verstovsek S, Iliescu C, Bhatti K, Palaskas N, Kim P, Gray B, Faiz S. Effect of Pulmonary Hypertension and Other Cardiovascular Diseases in Overall Prognosis of Patients with Myelofibrosis. Blood 132(Suppl 1):4310-4310, 2018. e-Pub 2018.

Book Chapters

1. Beinart, N, Palaskas, NL. Complete Heart Block and Myocarditis Related to Immune Checkpoint Inhibitor Therapy, 3-8, 2025.
2. Jensen, G, Palaskas, NL, Luo, W, Chang, J. Novel Biomarkers of Cardiovascular Disease, V2-409-V2-435, 2023.
3. Kaczmarek, J, Palaskas, NL. Cardiology (Heart), 7-27, 2022.
4. Palaskas, NL, Yang, EH, Neilan, TG. Immune Checkpoint Inhibitor (ICI)-Associated Myocarditis, 27-37, 2021.
5. Zarifa, A, Lopez-Mattei, J, Palaskas, NL, Iliescu, C, Durand, J, Kim, P. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity, 377-387, 2021.
6. Zarifa A, Lopez-Mattei J, Palaskas N, Iliescu C, Durand JB, Kim P. Immune checkpoint Inhibitors (ICIs)-Related Cardiotoxicity. In: Immunotherapy 4th Edition. 2021, 2021.
7. Palaskas NL, Yang EH, Neila TG. Immune Checkpoint Inhibitor (ICI)- Associated Myocarditis. In: Atlas of Imaging in Cardio-Oncology. Springer, 27-37, 2021.
8. Quintana-Quezada, RA, Palaskas, NL, Banchs, J. Hemodynamic evaluation and echocardiography in the oncologic intensive care unit, 753-773, 2019.
9. Quintana RA, Palaskas N, Banchs J. Hemodynamic Evaluation and Echocardiography in the Oncologic Intensive Care Uni. In: Oncologic Critical Care. Springer, 1-21, 2019.
10. Palaskas N, Ewer MS. Cardiac Monitoring During Clinical Trials. In: Cancer and the Heart 3rd Edition, 2019.
11. Palaskas, NL, Levine, GN. Echocardiography, 53-64, 2017.
12. Palaskas N, Levine G. Echocardiography. In: Cardiology Secrets. 5th Edition. Glenn Levine. Elselvier, 54-64, 2017.
13. Shah, T, Palaskas, NL, Bozkurt, B. Heart failure, introduction, 3-20, 2015.
14. Shah T, Palaskas N, Bozkurt B. "Heart Failure, Introduction" Pathophysiology and Pharmacotherapy of Cardiovascular Disease. In: Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Gowraganahalli Jagadeesh. Springer International Publishing, 3-20, 2015.

Books (edited and written)

1. Noman P, Kaczmarek J, Palaskas N, Brown A, Masterson W, Patel A, Varghese J, Best C, Thomas A, Wang Y, Oo T, Rojas-Hernandez C, Zhang H, Wang L, Miller E, Malek A, Okhuysen P, Mamlouk O, Lin J, Abudayyeh A, Tummala S, Raviskanthan S, Chu M, Mortensen P, Lee A, Al-Zubidi N, Thomas A, Zhang H, Wang Y, Chari S, Lai Z, Tong Y, Tan D, Verma D, Faiz S, Shannon V, Altan M, Sheshadri A, Kim S, Bowman S, Lu H. Managing Immunotherapy Related Organ Toxicities, 2022.